[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pure Bioscience Inc (PURE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

December 2018 | 29 pages | ID: PAB7063E09DEN
GlobalData

US$ 250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

Pure Bioscience Inc (Pure) is involved in the development and commercialization of proprietary antimicrobial products. The company markets and develops proprietary antimicrobial products principally in the food safety field providing solutions to the health and environmental challenges of pathogen and hygienic control. Pure’s technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate (SDC), a broad-spectrum, non-toxic antimicrobial agents. It also manufactures and sells SDC-based formulations to manufacturers for use as a raw material ingredient in the production of personal care products. Pure is headquartered in El Cajon, California, the US.

Pure Bioscience Inc (PURE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Pure Bioscience Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018
Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018
Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018
Pure Bioscience Inc, Medical Devices Deals, 2012 to YTD 2018
Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018
Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deal Details
Partnerships
Pure Bioscience Enters Into Co-Marketing Agreement With Intercon Chemical
Licensing Agreements
Pure Bioscience Enters into Licensing Agreement with Research Instruments
Equity Offering
PURE Bioscience Raises USD1.5 Million in Private Placement of Shares
Pure Bioscience Raises USD1.3 Million in Private Placement of Shares upon Exercise of Warrants
Pure Bioscience Raises USD6 Million in Private Placement of Shares
Pure Bioscience Completes Public Offering Of Shares For US$5 Million
Pure Bioscience Completes Private Placement Of Shares For US$1 Million
Pure Bioscience Inc - Key Competitors
Pure Bioscience Inc - Key Employees
Pure Bioscience Inc - Locations And Subsidiaries
Head Office
Recent Developments
Financial Announcements
Oct 25, 2018: PURE Bioscience reports fiscal 2018 year-end financial results
Jun 13, 2018: PURE Bioscience Reports Fiscal 2018 Third Quarter and Nine-Month Financial Results
Dec 14, 2017: PURE Bioscience Reports Fiscal 2018 Q1 Financial Results
Mar 02, 2017: PURE Bioscience Reports Improved 2017 Fiscal Second Quarter and Six-Month Financial Results
Corporate Communications
Jul 02, 2018: PURE Bioscience Raises $500,000 in Unsecured Promissory Note - Appoints Ivan Chen to Board of Directors
Nov 02, 2017: PURE Bioscience Expands Board of Directors with Appointment of Elisabeth Hagen, M.D., Food Safety Consultant
Legal and Regulatory
Apr 27, 2017: PURE Bioscience Receives USDA Permission Letter and FDA FCN Acknowledgement Letter
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Key Facts, 2018
Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Pure Bioscience Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018
Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018
Pure Bioscience Inc, Deals By Therapy Area, 2012 to YTD 2018
Pure Bioscience Inc, Medical Devices Deals, 2012 to YTD 2018
Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018
Pure Bioscience Enters Into Co-Marketing Agreement With Intercon Chemical
Pure Bioscience Enters into Licensing Agreement with Research Instruments
PURE Bioscience Raises USD1.5 Million in Private Placement of Shares
Pure Bioscience Raises USD1.3 Million in Private Placement of Shares upon Exercise of Warrants
Pure Bioscience Raises USD6 Million in Private Placement of Shares
Pure Bioscience Completes Public Offering Of Shares For US$5 Million
Pure Bioscience Completes Private Placement Of Shares For US$1 Million
Pure Bioscience Inc, Key Competitors
Pure Bioscience Inc, Key Employees

LIST OF FIGURES

Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018
Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018
Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018
Pure Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018
Pure Bioscience Inc, Medical Devices Deals, 2012 to YTD 2018


More Publications